secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0000950103-24-006128
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics enters $1B credit agreement; $250M term loan, $750M revolver due 2029
--------------------------------------------------------------------------------

- New $250M senior unsecured term loan retires existing term loan under 2022 credit agreement.
- Revolving credit facility increased by $330M to $750M from prior $420M.
- Maturity extended to April 30, 2029, with quarterly amortization increasing over term.
- Interest rate: Adjusted Term SOFR plus spread of 1.125% to 1.750% based on leverage ratio.
- Financial covenants: max leverage 4.00x (4.50x after material acquisition), min interest coverage 3.50x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000095010324006128/0000950103-24-006128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000095010324006128/dp210533_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-006128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer